Paul Schimmel's Net Worth
Paul Schimmel's net worth is estimated to be at least $15,739,623.75 as of 12/23/2024. CoreStreet's estimation of Paul Schimmel's net worth is based on their sale of stock and current holding of stock.
Paul Schimmel is Director at aTyr Pharma, Inc.. They have executed at least 27 trades of stock as per SEC Form 4 filings. Their most recent trade was for 52,300 units of ATYR stock on 07/24/2024. Their biggest sale was on 03/13/2018 when they sold 27,823 units of Alnylam Pharmaceuticals Inc stock for $4,173,450.00. They typically trade 2 times per year.
Total value of insider buys:
- $5,685,573.75
Total value of insider sells:
- $10,054,050.00
Most recent insider trade:
- July 24, 2024
Paul Schimmel's Insider Trading History
| aTyr Pharma, Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 24, 2024 | Director | 52,300 | $1.93 | Buy | $100,939.00 |
July 22, 2024 | Director | 41,052 | $1.74 | Buy | $71,430.48 |
| aTyr Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 10, 2023 | Director | 200,000 | $2.25 | Buy | $450,000.00 |
Sept. 20, 2021 | Director | 250,000 | $8.00 | Buy | $2,000,000.00 |
May 18, 2021 | Director | 50,000 | $3.98 | Buy | $199,000.00 |
Feb. 10, 2020 | Director | 254,000 | $4.00 | Buy | $1,016,000.00 |
Nov. 26, 2018 | Director | 147,225 | $0.54 | Buy | $79,501.50 |
Sept. 4, 2018 | Director | 42,749 | $0.74 | Buy | $31,634.26 |
Aug. 30, 2018 | Director | 164,411 | $0.74 | Buy | $121,664.14 |
May 18, 2018 | Director | 150,000 | $1.00 | Buy | $150,000.00 |
Aug. 31, 2017 | Director | 94,336 | $2.65 | Buy | $249,990.40 |
Dec. 21, 2016 | Director | 25,000 | $2.28 | Buy | $57,000.00 |
Dec. 16, 2016 | Director | 50,000 | $2.48 | Buy | $124,000.00 |
April 14, 2016 | Director | 66,219 | $4.18 | Buy | $276,795.42 |
April 13, 2016 | Director | 9,835 | $3.85 | Buy | $37,864.75 |
April 12, 2016 | Director | 9,127 | $3.71 | Buy | $33,861.17 |
April 11, 2016 | Director | 32,659 | $3.57 | Buy | $116,592.63 |
April 8, 2016 | Director | 85,000 | $3.22 | Buy | $273,700.00 |
April 7, 2016 | Director | 40,000 | $3.19 | Buy | $127,600.00 |
April 6, 2016 | Director | 25,000 | $3.20 | Buy | $80,000.00 |
April 5, 2016 | Director | 25,000 | $3.52 | Buy | $88,000.00 |
| Alnylam Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 13, 2018 | Director | 27,823 | $150.00 | Sell | $4,173,450.00 |
April 21, 2015 | Director | 10,000 | $130.02 | Sell | $1,300,200.00 |
Oct. 28, 2014 | Director | 15,000 | $95.00 | Sell | $1,425,000.00 |
Jan. 13, 2014 | Director | 15,000 | $85.36 | Sell | $1,280,400.00 |
Dec. 20, 2013 | Director | 15,000 | $65.00 | Sell | $975,000.00 |
Oct. 22, 2013 | Director | 15,000 | $60.00 | Sell | $900,000.00 |